tiprankstipranks
Trending News
More News >
Pfizer (DE:PFE)
XETRA:PFE
Germany Market
Advertisement

Pfizer (PFE) Technical Analysis

Compare
194 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Pfizer’s (PFE) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pfizer is a Buy.
Pfizer’s (PFE) 20-Day exponential moving average is 21.40, while Pfizer’s (PFE) share price is €21.44, making it a Buy.
Pfizer’s (PFE) 50-Day exponential moving average is 21.29, while Pfizer’s (PFE) share price is €21.44, making it a Buy.

Pfizer (PFE) Pivot Points

Oct 23, 2025, 02:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.07
21.13
21.24
21.30
21.40
21.46
21.57
Fibonacci
21.13
21.20
21.24
21.30
21.36
21.40
21.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pfizer (PFE) Moving Averages

Oct 23, 2025, 02:08 PM
Period
Simple
Exponential
MA5
21.14Buy
21.28Buy
MA10
21.28Buy
21.36Buy
MA20
21.60Sell
21.40Buy
MA50
21.32Buy
21.29Buy
MA100
21.09Buy
21.25Buy
MA200
21.59Sell
21.86Sell
Pfizer’s (PFE) 10-Day exponential moving average is 21.36, while Pfizer’s (PFE) share price is €21.44, making it a Buy.
Pfizer’s (PFE) 100-Day exponential moving average is 21.25, while Pfizer’s (PFE) share price is €21.44, making it a Buy.
Pfizer’s (PFE) stock price is €21.44 and Pfizer’s (PFE) 50-day simple moving average is 21.32, creating a Buy signal.
Pfizer’s (PFE) stock price is €21.44 and Pfizer’s (PFE) 100-day simple moving average is 21.09, creating a Buy signal.
Pfizer’s (PFE) stock price is €21.44 and Pfizer’s (PFE) 200-day simple moving average is 21.59, creating a Sell signal.

Pfizer (PFE) Technical Indicators

Oct 23, 2025, 02:08 PM
Name
Value
Implied Action
RSI (14)
50.94
Neutral
STOCH (9,6)
45.23
Neutral
STOCHRSI (14)
25.12
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
15.17
Buy
Williams %R
-70.24
Buy
CCI (14)
-14.88
Neutral
ATR (14)
0.43
-
Ultimate Oscillator
45.03
Neutral
ROC
-6.60
Sell
Pfizer’s (PFE) Relative Strength Index (RSI) is 50.94, creating a Neutral signal.
Pfizer’s (PFE) Trend Strength Indicator (ADX) is 15.17, creating a Buy signal.
Pfizer’s (PFE) Commodity Channel Index (CCI) is -14.88, creating a Neutral signal.
Pfizer’s (PFE) Price Rate of Change (ROC) is -6.60, creating a Sell signal.

FAQ

Is PFE a Buy, Hold, or Sell?
Based on PFE’s technical indicators, PFE is a Buy.
    What is PFE’s RSI (14)?
    PFE’s RSI (14) is 50.94, which suggests PFE is a Neutral.
      What is PFE’s MACD?
      PFE’s MACD is >-0.01, which suggests PFE is a Buy.
        What is PFE’s 5-day moving average?
        PFE’s 5-day moving average is 21.14, which suggests PFE is a Buy.
          What is PFE’s 20-day moving average?
          PFE 20-day moving average is 21.60, which suggests PFE is a Sell.
            What is PFE’s 50-day moving average?
            PFE’s 50-day moving average is 21.32, which suggests PFE is a Buy.
              What is PFE’s 200-day moving average?
              PFE’s 200-day moving average is 21.59, which suggests PFE is a Sell.
                What is PFE’s Williams % R (14)?
                PFE’s Williams % R (14) is -70.24, which suggests PFE is a Buy.
                  What is PFE’s CCI (14)?
                  PFE’s CCI (14) is -14.88, which suggests PFE is a Neutral.
                    What is the share price of Pfizer?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis